Table 3.
Index | Visit | Group | N | Mean | SD | P-value |
---|---|---|---|---|---|---|
FEV1 | Baseline | YuPingFeng | 120 | 1.17 | 0.35 | – |
Placebo | 120 | 1.13 | 0.38 | – | ||
52 weeks | YuPingFeng | 97 | 1.21 | 0.49 | 0.417 | |
Placebo | 87 | 1.15 | 0.40 | 0.779 | ||
FVC | Baseline | YuPingFeng | 120 | 2.36 | 0.67 | – |
Placebo | 120 | 2.36 | 0.74 | – | ||
52 weeks | YuPingFeng | 97 | 2.36 | 0.71 | 0.677 | |
Placebo | 87 | 2.34 | 0.65 | 0.412 | ||
FEV1/FVC% | Baseline | YuPingFeng | 120 | 50.85 | 11.23 | – |
Placebo | 120 | 49.25 | 11.05 | – | ||
52 weeks | YuPingFeng | 97 | 51.68 | 13.61 | 0.507 | |
Placebo | 87 | 49.59 | 11.94 | 0.920 |
Abbreviations: FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.